Pharmaceutical Executive-10-01-2007
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Pharmaceutical Executive Daily: FDA Approves Lipfendra
3
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5